Core Viewpoint - The company is providing guarantees for its subsidiaries to secure a total bank credit line of up to 7.765 billion RMB to support their operational needs [1][4]. Group 1: Guarantee Overview - The company has approved a total guarantee amount of 4.25 billion RMB for its subsidiaries, which will be provided as joint liability guarantees [3]. - The guarantee is aimed at meeting the operational development needs of the subsidiaries, which are performing normally and have stable financial conditions [3][4]. Group 2: Subsidiary Information - The subsidiaries involved in the guarantee include: - Luoyang Daclin Pharmaceutical Co., Ltd. - Xuchang Daclin Baoyuantang Pharmacy Chain Co., Ltd. - Henan Daclin Pharmaceutical Logistics Co., Ltd. - Guangxi Daclin Pharmaceutical Co., Ltd. - Wuzhou Daclin Chain Pharmacy Co., Ltd. - Daclin (Zhejiang) Pharmaceutical Co., Ltd. - Foshan Daclin Pharmaceutical Trading Co., Ltd. [2] Group 3: Financial Metrics - As of the announcement date, the total external guarantee balance of the company and its subsidiaries is 42.575 billion RMB, which accounts for 52.31% of the latest audited net assets attributable to shareholders [5].
大参林医药集团股份有限公司关于为子公司提供担保的进展公告